Quantitative Assessments of Pupillary Light Reflexes in Hospital-Onset Unconsciousness

DOI: https://doi.org/10.21203/rs.3.rs-107836/v1

Abstract

Background

Patients who develop hospital-onset unconsciousness should be promptly managed in order to avoid clinical deterioration. Pupillary examination through pupillary light reflex is the mainstay method in the initial evaluation of unconscious patients, but the current method of light shedding and subjective description often shows poor reliability. The objective of this study is to explore whether a quantitative measurement of pupillary light reflexes is useful in detecting brain herniation syndrome and predicting neurological outcomes in non-neurological patients who developed hospital-onset unconsciousness.

Methods

This was a registry-based observational study on patients who activated the neurological rapid response team at Asan Medical Center (Seoul, Korea). Hospital-onset unconsciousness was defined as a newly developed stupor or comatose state during admission. Demographics, comorbidities, pupillometry parameters including Neurological Pupil index, brain herniation syndrome, in-hospital mortality, and modified Rankin Scale at 3-months were analyzed.

Results

In 214 consecutive patients with hospital-onset unconsciousness, 37 (17%) had brain herniation syndrome. The optimal cut-off value of Neurological Pupil index for detecting brain herniation syndrome was < 1.6 (specificity, 91% [95% confidence interval (CI) = 86−95]; sensitivity, 49% [95% CI = 32−66]). The in-hospital mortality rate was 28% (59/214); the Neurological Pupil index was negatively associated with in-hospital mortality after adjustments for the presence of brain herniation syndrome (adjusted odds ratio = 0.77, 95% CI = 0.62–0.96). Poor neurological outcomes (modified Rankin Scale ≥ 4) at 3 months was observed in 76% (152/201) of the patients; the Neurological Pupil index was negatively associated with poor neurological outcomes after adjustments for clinical variables (adjusted odds ratio = 0.67, 95% CI = 0.49–0.90).

Conclusions

Quantitative measurements of pupillary light reflexes may be useful for early detection of potentially life-threatening neurological conditions in patients with hospital-onset unconsciousness.

Introduction

Unconsciousness is one of the most common complaints in patients during emergency department visits and hospitalizations [1]. Various causes underlie unconsciousness, including metabolic encephalopathy, brain structural lesions, meningoencephalitis, and seizure disorders. Early management of the underlying causes as well as the clinical symptoms should be promptly provided in order to avoid clinical deterioration, morbidity, and mortality [2]. Hospitalized patients generally have more comorbidities and are sicker than the general population; hence, the etiologies and outcomes of sudden unconsciousness may differ between in-hospital patients and outpatients. Nevertheless, comprehensive studies on the early evaluations and long-term outcomes of hospital-onset unconsciousness (HOU) are lacking.

Pupillary examinations are the mainstay in the initial evaluation of unconscious patients [3]. The assessments of pupils include diameter, shape, symmetry, and light reflexes. Evaluation of the pupillary light reflexes (PLR) is conventionally performed by shedding light into the patient’s eye and subjectively described by examiners. However, such conventional assessments of PLR have low inter-rater and intra-rater correlations [4, 5]. Recently, quantitative pupillometery (QP) was introduced to the neurocritical care field to provide objective assessments of the PLR. QP is able to detect subtle early changes in the size and light reflexes of pupils [6]. This bedside tool is becoming popular in the routine evaluation of unconscious patients who are admitted to intensive care units and require serial measurements of pupils, especially for those with brain herniation syndrome (BHS) [710]. Moreover, QP was shown to be useful in neurological prognostication in unconscious patients after cardiac arrest [1117]. Because the PLR is regulated by the autonomic nervous system, QP may also have a role in the assessment of autonomic dysfunction in critically ill patients [18, 19]. However, studies on the QP findings in patients who are hospitalized outside intensive care units are lacking. Moreover, the clinical implication of the findings of sluggish pupils remains largely uninvestigated in unconscious patients, although fixed dilated pupils inarguably suggest urgent situations and grave prognosis [3].

Here, we investigated whether quantitative assessments of the PLR through QP measurement indicates the presence of BHS in non-neurological patients who developed HOU. We also explored which QP parameters are related to clinical outcomes in such patients.

Methods

Patients

This registry-based longitudinal observational study was performed between September 1, 2017 and November 30, 2018 at Asan Medical Center, a tertiary hospital located in Korea. All data for the current study have been collected and documented on the registry of the Neurological Alert Team (NAT), a round-the-clock neurologist-led rapid response team organized for the improvement of hospital-wide performance in response to in-patient medical emergency.[20] For this study, we included patients who were (1) 18 years of age or older, (2) admitted to non-neurological departments, and (3) activated the NAT due to hospital-onset unconscious state (ie, stupor or comatose state) as assessed by the ACDU (Alert, Confused, Drowsy, and Unresponsive) scale, which is a simple four-point scale for assessing patients presenting with altered mental status.[21] The NAT neurologists or clinical nurse specialists routinely measured the patients’ pupils by using QP for initial neurological assessment during office hours. We excluded patients with no available QP measurements, incomplete demographic data, or unconsciousness following cardiac arrest. This study was approved by the institutional review board of Asan Medical Center and the need for written informed consent was waived considering the retrospective nature of the study.

Clinical Assessments

According to our protocol, the neurologists performed initial neurological assessments as soon as possible following NAT activation. Systematic evaluations including vital signs, ACDU scale, Glasgow Coma Scale (GCS), laboratory tests, computed tomography (CT) and/or magnetic resonance imaging (MRI) of the brain, and electroencephalography (EEG) were conducted. Clinical outcomes were assessed by the survival status at hospital discharge and the modified Rankin Scale (mRS) at 3 months after the NAT activation. Neurological status was categorized into good (mRS = 0–3) and poor (mRS = 4–6) [22]. All data were prospectively documented in our registry and were reviewed and adjudicated by the investigators at weekly conferences.

Pupillometry Measurements

QP was measured at bedside using the NPi-100 pupillometer (NeurOptics, Irvine, CA, USA). The detection thresholds were 10.00 mm for the maximum pupil diameter (Max), 1.00 mm for the minimum pupil diameter (Min), and 0.03 mm for the change in size. The QP parameters included Max (mm), Min (mm), percentage of change (CH = 100 × [Max – Min]/Max), constriction velocity (CV, mm/sec), latency of constriction (Lat, msec), dilation velocity (DV, mm/sec), and Neurological Pupil index (NPi). NPi is a scale with values ranging from 0.0 to 5.0, and its algorithm is derived from a normative model with values measured from healthy volunteers.[8] Low NPi value can be interpreted as less distinct PLR (ie, decreased pupillary reactivity). All QP assessments were performed at least twice in each eye. Among the repetitive QP measurements, the dataset with the maximum NPi value content was documented for each eye. From the results measured on each eye, lower (NPi, CH, CV, DV) or higher (Max, Min, Lat) values for either eye were used for analysis.

Etiology of Hospital-Onset Unconsciousness

The causes of HOU were categorized as follows: (1) metabolic encephalopathy (eg, sepsis, organ dysfunction, electrolyte imbalance, and drug side effects); (2) ischemic stroke; (3) hemorrhagic stroke; (4) intracranial bleeding (subdural or epidural); (5) brain tumor (primary or metastatic); (6) meningoencephalitis; (7) seizure-related events (convulsive or non-convulsive seizure, status epilepticus, or postictal status); (8) hypoxic-ischemic encephalopathy; and (9) other causes (eg, syncope, pseudocoma, and cerebral concussion). In case an HOU had multiple causes, their contributions to the HOU were ranked.

The presence of BHS was radiographically and clinically evaluated. We defined BHS as the development of acute brain lesions that were relevant to the unconsciousness, including midline shift, brainstem compression, hydrocephalus, and diffuse cerebral edema [23]. All CT scans and MRI sequences were jointly interpreted by two investigators who were blinded to the QP data and clinical outcomes. A third investigator was consulted in cases of disagreement.

Statistical Analyses

Data are summarized as mean ± standard deviation for normally distributed continuous variables, medians and interquartile ranges for non-normally distributed continuous variables, and frequencies with percentages for categorical variables. Univariable analyses were carried out to identify the relationship between each variable and BHS or clinical outcomes; categorical variables were compared with Pearson’s χ2 test or Fisher’s exact test, and continuous variables were compared with the Student’s t-test. Variables with p values < 0.1 in the univariable analysis were included as candidate variables in the multivariable logistic regression model and removed by backward stepwise selection. We further performed all analyses using a forward selection procedure to confirm the final model. All QP variables significantly associated with BHS or clinical outcomes in the univariable analysis were individually added to the final clinical models to generate the odds ratio (OR) and the 95% confidence intervals (CIs) thereof. To analyze the usefulness of QP for the prediction of BHS, we calculated the predictive accuracy by sensitivity, specificity, negative predictive value, and positive predictive value. Two-tailed p values < 0.05 were considered statistically significant. All statistical analyses were performed using R version 3.6.2 (R Foundation for Statistical Computing, Vienna, Austria) and GraphPad Prism, version 8.3.1 (GraphPad Software, La Jolla, CA, USA).

Results

Patient Characteristics

A total of 1,442 patients activated the NAT during the study period. We included 404 (28%) patients who were in an unresponsive state as assessed by the ACDU scale at the time of on-call consultations to the NAT; and excluded 190 patients who either did not have QP measurements due to NAT activation during after-hours (n = 129), showed unconsciousness following cardiac arrest (n = 46), or had incomplete demographic data (n = 15). Thus, the remaining 214 patients were included in the final analysis; their mean age was 63.9 ± 14.9 years, and 127 (59%) were men. The baseline characteristics of the 214 patients are presented in Table 1.

Table 1

Baseline Characteristics

Factor

n = 214

Age, yr, mean ± standard deviation

63.9 ± 14.9

Male sex, n (%)

127 (59.3)

Modified Rankin Scale before admission ≥ 4, n (%)

72 (33.6)

Comorbidities

 

Hypertension, n (%)

101 (47.2)

Diabetes mellitus, n (%)

69 (32.2)

Cardiac disease, n (%)

83 (38.8)

Chronic lung disease, n (%)

21 (9.8)

Chronic liver disease, n (%)

35 (16.4)

Chronic kidney disease, n (%)

41 (19.2)

Cancer, n (%)

85 (39.7)

Organ transplantation, n (%)

19 (8.9)

Previous stroke, n (%)

34 (15.9)

Findings on NAT activation

Glasgow Coma Scale, median (interquartile ranges)

6 (3–8)

Hypotension, n (%)

16 (7.5)

Tachycardia, n (%)

125 (58.4)

NAT Neurological Alert Team

Etiology of Hospital-Onset Unconsciousness

Of the included patients, 195 (91%) underwent CT and/or MRI of the brain, which showed acute intracranial lesions in 104 (53%) patients. Of them, 91 patients had brain lesions relevant to the HOU and 13 patients had brain lesions that were irrelevant to the HOU (acute small infarcts). EEG was performed in 174 (81%) patients, including continuous EEG monitoring in 25 patients. The identified causes of HOU in 214 patients are shown in Fig. 1. The most common cause of HOU was metabolic encephalopathy (44% [95/214]), followed by seizure-related events (29% [61/214]) and ischemic stroke (8.9% [19/214]).

Brain Herniation Syndrome

BHS was found in 37 (17%) patients, who showed higher in-hospital mortality rate compared with those without BHS (57% [21/37] vs. 21% [38/177]; p < 0.001). The diagnoses of the patients with BHS were hemorrhagic stroke (n = 10), ischemic stroke (n = 6), acute liver failure (n = 6), brain tumor or leptomeningeal seeding with acute hydrocephalus (n = 6), hypoxic-ischemic brain injury (n = 3), meningoencephalitis (n = 2), subdural hemorrhage (n = 2), cerebral venous thrombosis (n = 1), and unknown etiology of diffuse cerebral edema (n = 1). In univariable analysis, younger age, good functional status before admission, absence of a history of hypertension or diabetics, and lower GCS score at NAT activation were significantly associated with the risk of BHS (Table 2). Among the QP parameters, lower NPi, larger Max, and larger Min showed independent association with the risk of BHS on multivariable analysis. The NPi cut-off value of < 1.6 provided the maximum area under the receiver operating characteristic (ROC) curve (0.750) for predicting BHS, with a sensitivity of 49% (95% CI = 32 − 66) and a specificity of 91% (95% CI = 86 − 95). In addition, the positive predictive value and negative predictive value of this NPi cut-off value for predicting BHS were 53% (95% CI = 39 − 67) and 89% (95% CI = 86 − 92), respectively.

Table 2

Factors Associated with the Presence of Brain Herniation Syndrome

Factor

Univariable analysis

OR (95% CI)

p value

Multivariable analysis

Adjusted OR (95% CI)

p value

Age, yr

0.95 (0.93–0.97)

< 0.001

0.97 (0.94–0.99)

0.014

Male sex

1.00 (0.49–2.10)

0.987

   

Modified Rankin Scale before admission ≥ 4

0.32 (0.11–0.77)

0.017

   

Comorbidities

Hypertension

0.40 (0.18–0.85)

0.021

   

Diabetes mellitus

0.27 (0.09–0.68)

0.011

   

Cardiac disease

0.71 (0.32–1.49)

0.384

   

Chronic lung disease

0.47 (0.07–1.74)

0.331

   

Chronic liver disease

2.25 (0.94–5.12)

0.058

   

Chronic kidney disease

0.32 (0.07–0.96)

0.072

   

Cancer

1.04 (0.49–2.13)

0.911

   

Previous stroke

0.59 (0.16–1.63)

0.357

   

Findings on NAT activation

Glasgow Coma Scale

0.79 (0.67–0.93)

0.005

0.83 (0.71–0.98)

0.027

Hypotension

1.61 (0.43–4.97)

0.431

   

Tachycardia

1.78 (0.83–4.10)

0.151

   

Quantitative measures on pupillometry

NPi

0.54 (0.42–0.68)

< 0.001

0.57 (0.45–0.74)

< 0.001

Max, mm

1.75 (1.32–2.37)

< 0.001

1.54 (1.14–2.09)

< 0.001

Min, mm

1.74 (1.23–2.54)

0.002

1.51 (1.03–2.21)

0.034

CH, %

0.96 (0.92–1.00)

0.066

   

CV, mm/sec

0.76 (0.46–1.20)

0.273

   

Lat, msec

1.00 (0.99–1.00)

0.227

   

DV, mm/sec

0.42 (0.14–1.16)

0.111

   
CH percentage of change (CH = 100 × [Max – Min]/Max), CI confidence interval, CV constriction velocity, DV dilation velocity, Lat latency of constriction, Max maximal pupillary diameter, Min minimal pupillary diameter, NAT Neurological Alert Team, NPi Neurological Pupil index, OR odds ratio,

In-Hospital Mortality

In-hospital mortality was noted in 59 (28%) patients. The presence of hemorrhagic stroke (12% [7/59] vs. 3.2% [5/155], p = 0.034) and presence of BHS (36% [21/59] vs. 10% [16/155], p < 0.001) were significantly associated with in-hospital mortality. NPi was significantly lower in patients with in-hospital mortality than in those without (3.2 [1.2 − 4.2] vs. 4.0 [3.2 − 4.4], p = 0.001). The following QP variables were also significantly associated with in-hospital mortality: smaller CH (14.5 ± 9.3 vs. 20.0 ± 10.5%, p = 0.001), slower CV (1.0 ± 0.8 vs. 1.4 ± 0.9 mm/sec, p = 0.004), longer Lat (331.8 ± 69.0 vs. 297.4 ± 51.9 msec, p = 0.002), and slower DV (0.4 ± 0.4 vs. 0.6 ± 0.4 mm/sec, p = 0.005). In multivariable analysis, the presence of BHS (OR = 4.80, 95% CI = 2.28–10.09, p < 0.001), NPi (OR = 0.77, 95% CI = 0.62–0.96, p = 0.019), CH (OR = 0.95, 95% CI = 0.92–0.98, p = 0.004), CV (OR = 0.56, 95% CI = 0.36–0.86, p = 0.008), Lat (OR = 1.01, 95% CI = 1.00–1.02, p = 0.001), and DV (OR = 0.32, 95% CI = 0.13–0.78, p = 0.011) were independently associated with in-hospital mortality.

Neurological Outcomes

A total of 201 (94%) patients had available data on mRS at 3 months. Poor neurological outcome was noted in 152 (76%) patients. Table 3 shows the factors associated with poor neurological outcomes in patients with HOU, which included age, pre-admission mRS ≥ 4, diabetes mellitus, cancer, and previous stroke. The following QP Parameters were also associated with poor neurological outcomes at 3 months: NPi, CH, CV, Lat, and DV. Multivariable analysis showed that pre-admission mRS ≥ 4, cancer, previous stroke, NPi, CH, Lat, and DV were significantly associated with poor neurological outcomes at 3 months. The area under the ROC curve for poor neurological outcomes at 3 months was 0.762 in the model with clinical variables (pre-admission mRS ≥ 4, cancer, and previous stroke). Upon addition of the QP variables (NPi, CH, Lat, and DV), the area under the ROC curve for poor neurological outcomes at 3 months was increased to 0.837 (Fig. 2).

Table 3

Factors Associated with Poor Neurological Outcomes at 3-months

Factor

Univariable analysis

OR (95% CI)

p value

Multivariable analysis

Adjusted OR (95% CI)

p value

Age, yr

1.03 (1.01–1.06)

< 0.001

   

Male sex

1.47 (0.76–2.82)

0.241

   

Modified Rankin Scale before admission ≥ 4

17.09 (5.03–107.0)

< 0.001

13.7 (3.14–60.6)

< 0.001

Comorbidities

Hypertension

0.86 (0.45–1.65)

0.661

   

Diabetes mellitus

2.66 (1.25–6.22)

0.015

   

Cardiac disease

1.00 (0.51–1.98)

0.989

   

Chronic lung disease

0.96 (0.35–3.09)

0.945

   

Chronic liver disease

1.00 (0.43–2.54)

0.984

   

Chronic kidney disease

1.91 (0.79–5.35)

0.176

   

Cancer

2.24 (1.12–4.69)

0.025

2.24 (1.00–5.00)

0.031

Previous stroke

5.30 (1.51–33.6)

0.026

4.89 (1.05–22.7)

0.043

Findings on NAT activation

Glasgow Coma Scale

0.89 (0.77–1.01)

0.091

   

Hypotension

1.17 (0.34–5.37)

0.809

   

Tachycardia

1.01 (0.50–2.00)

0.960

   

Etiology of hospital-onset unconsciousness

Brain herniation syndrome

1.69 (0.69–4.75)

0.276

   

Ischemic stroke

2.76 (0.74–17.9)

0.185

   

Hemorrhagic stroke

3.74 (0.70–69.3)

0.211

   

Subdural hemorrhage

1.29 (0.18–25.7)

0.817

   

Metabolic encephalopathy

1.07 (0.56–2.08)

0.817

   

Seizure

0.56 (0.28–1.12)

0.098

   

Quantitative measures on pupillometry

NPi

0.72 (0.54–0.93)

0.020

0.67 (0.49–0.90)

0.009

Max, mm

0.95 (0.74–1.21)

0.695

   

Min, mm

1.08 (0.78–1.54)

0.619

   

CH, %

0.95 (0.92–0.98)

0.008

0.96 (0.93–1.00)

0.046

CV, mm/sec

0.57 (0.39–0.83)

0.003

   

Lat, msec

1.01 (1.00-1.02)

< 0.001

1.01 (1.00-1.02)

0.002

DV, mm/sec

0.27 (0.12–0.60)

0.001

0.34 (0.14–0.84)

0.019

Neurological outcomes were dichotomized into good outcome (mRS of 0–3) and poor outcome (mRS of 4–6).
CH percentage of change (CH = 100 × [Max – Min]/Max), CI confidence interval, CV constriction velocity, DV dilation velocity, Lat latency of constriction, Max maximal pupillary diameter, Min minimal pupillary diameter, mRS modified Rankin Scale, NAT Neurological Alert Team, NPi Neurological Pupil index, OR odds ratio,

Discussion

In this registry-based observational study, we showed that the application of QP was useful for detecting BHS and predicting clinical outcomes in patients with HOU. When the patients’ altered mental status activated the neurological rapid response team, the initial detection of reduced pupillary reactivity (lower values of NPi) as well as enlarged pupillary size (Max and Min) were significantly associated with later identifications of BHS. The specificity and negative predictive value of the finding of NPi < 1.6 were as high as ~ 90% in predicting the presence of BHS, while the sensitivity and positive predictive value were relatively low at ~ 50%. QP parameters indicating reduced pupillary reactivity were also significantly associated with in-hospital mortality (lower values of NPi, CH, CV, and DV, and higher values of Lat) and poor neurological outcome at 3 months (lower values of NPi, CH, and DV, and higher values of Lat). The addition of QP in considering the patients’ medical conditions enhanced the prediction value (larger area under the ROC curve) of mRS at 3 months. To the best of our knowledge, this is the first study to show the prognostic value of measuring QP in patients who are admitted for non-neurological illness and develop sudden unconsciousness.

In terms of the etiologies of HOU, we found that metabolic encephalopathy was the most common cause, followed by seizure-related events, ischemic and hemorrhagic strokes, and metastatic and primary brain tumors. Approximately 43% of our study population had acute diseases of the brain such as stroke, intracranial bleeding, brain tumor, meningoencephalitis, and hypoxic-ischemic brain injury. BHS, one of the most severe life-threatening neurologic emergencies, was found in 17% of patients with HOU and was caused by massive cerebral infarcts, subdural hemorrhage, or diffuse brain swelling related to metabolic conditions (eg, acute liver failure). Seizure-related events including convulsive seizure, nonconvulsive status epilepticus, and postictal state were also as frequent as 29%.

We found that the use of QP may be useful for the early detection of BHS. The pupillary examination is a crucial component in the initial evaluation of unconscious patients, but early signs of pupils relevant to BHS can be nonspecific or elusive despite careful examination. In emergency situations, it is challenging to quickly perform and properly interpret neurological examinations, especially in hospitalized patients with multiple comorbidities. According to the experience of our rapid response team, QP is a practical tool when used in addition to routine neurological examination, because it is portable and can be quickly performed at bedside. In a previous preliminary observational study, midline shift and increased intracranial pressure were associated with a decrease of CV below 0.6 mm/sec; however, patients with diffuse brain edema and without midline distortion did not show such a decrease in CV until the intracranial pressure exceeded 30 mmHg [10]. In our study, 13 of 37 patients with BHS had diffuse brain swelling but did not have midline shifts, which may account for the absence of differences in CV between the BHS and non-BHS groups. Nevertheless, we demonstrated that the NPi value of less than 1.6 has a high specificity and a high negative predictive value for detecting BHS in patients with HOU. Collectively, these findings suggest that patients who develop unconsciousness during the hospital admission and show decreased NPi value on QP measurements would benefit from undergoing expeditious neuroimaging studies to detect BHS.

Traditionally, the PLR has been rather subjectively assessed by using a variety of non-standardized light sources by practitioners with varying levels of skills in neurological examinations. Recent studies have shown that such subjective assessments of pupillary reactivity have subpar reliability, with low inter-rater and intra-rater correlations [4, 5]. Recently, the QP has become popular as it provides a non-invasive, hand-held implementation of neuro-monitoring. QP also offers an objective and standardized measurement of the PLR, and mean QP values in healthy volunteers (Max 3.5–5.3 mm, Min 2.4–3.4 mm, CH 29–36%, Lat 0.22–0.27 sec, CV 1.5–2.9 mm/sec, and DV 0.9–2.2 mm/sec) have been suggested in prior studies [7, 10, 2426]. Additionally, the automated algorithm of QP provides an NPi value derived from a combination of QP variables. An NPi score below 3.0 is generally considered an abnormal finding of sluggish light reflex [8]. Preliminary studies conducted in intensive care units reported the usefulness of QP for detecting a wide range of conditions including increased intracranial pressure [710]. response to osmotherapy [27], discrimination between compressive lesions and microvascular ischemic oculomotor nerve palsy [28], assessment of disease severity of aneurysmal subarachnoid hemorrhage [29], the depth of sedation and analgesia [30], and neurological prognostication in comatose resuscitation-of-spontaneous-circulation following cardiac arrest [1117]. The prognostic implication of QP has been only investigated in patients with cardiac arrest [1117], in whom a decrease in NPi values less than 2.0 was associated with unfavorable neurological outcomes [13]. Our results showed that the QP was useful in detecting BHS and predicting clinical outcomes in patients with HOU, and that decreased NPi values and increased pupillary sizes were significantly related to BHS. Decreased NPi values were also associated with in-hospital mortality and unfavorable neurological outcomes at 3-months. In terms of QP variables, the pupillary size (Max and Min) was not significantly related to mortality rate or neurological outcomes, whereas other QP variables such as CH, Lat, and DV were associated with clinical outcomes including in-hospital mortality and neurological status at 3-months. Therefore, a combination of QP variables may be more reliable than the NPi alone in the prediction of neurological outcomes, despite the high predictive value of the NPi. In summary, our results show that measurements of PLR with QP may be useful in the early detection of life-threatening neurological conditions and neuro-prognostication for patients with HOU.

Fixed or dilated pupils are generally ominous neurological signs, as sluggish or absent PLR may indicate the compression or stretching of the dorsal midbrain in which the Edinger-Westphal nuclei is located, or of the efferent oculomotor nerve that carries parasympathetic fibers [31]. Some studies suggested that the integrity and function of PLR may also be affected by the perfusion defect to the brainstem or alterations of neurotransmitter release [32, 33]. Furthermore, even though pupillary constriction by light stimulus is predominantly integrated by the parasympathetic nervous system, it is possible that sympathetic activities are also engaged in the regulation of the pupillary reactivity. First, the sympathetic nerves are involved in the dilation phase of PLR: the supranuclear inhibition via sympathetic neurons suppresses the pre-ganglionic parasympathetic neurons at the Edinger-Westphal nucleus, resulting in relaxation of the pupil sphincter muscle; also, the sympathetic neurons contract the iris dilator muscle via peripheral sympathetic innervation [31]. Second, the reticular activating system affects the pupil size and PLR by tonic inhibitory input of the Edinger-Westphal complex through releasing norepinephrine [34]. Third, cognitive and emotional processes may result in mydriatic reaction by the input of cortical innervation into the brainstem, although the exact circuits remain poorly understood [34, 35]. Thus, the dynamics of the pupil reactivity may be indicative of lesions or dysfunctions of the cortex, subcortex, and brainstem that affect the parasympathetic system, sympathetic system, neurotransmitters, and their complex interactions.

Further studies are needed to clarify the mechanism underlying the association between QP values and clinical outcomes in patients with HOU in the absence of BHS. It is possible that autonomic dysfunction, as well as multiorgan dysfunction and brain dysfunction (eg, metabolic encephalopathy and BHS) may underlie such association. Autonomic dysfunction mediated by inflammatory response likely has an important role in the pathogenesis of the dysfunction of the brain or other organs [36]. Neurotransmitter imbalance such as cholinergic deficiency due to inflammation and multiorgan dysfunction in critically ill patients can lead to pupillary dysfunction [18, 33]. In this context, although there is limited evidence on the association between QP values and the severity of encephalopathy [37], QP as an indicator of autonomic and brain dysfunction may play a role in assessing the severity of metabolic encephalopathy as the cause of HOU (Fig. 3).

In addition to the inherent limitations of its single-center retrospective design, the present study has the following limitations. First, we did not assess the pupillary dilation reflex, which may be evoked by sensory stimulation and predominantly mediated by the sympathetic nervous system. Instead, we measured the DV, which could reflect sympathetic activity during the dilation phase of the PLR. Second, concurrent use of drugs that could confound the evaluation of the PLR such as opioids, anticholinergics, or sedative agents was not evaluated. Although a previous study showed that the use of these medications within therapeutic doses does not significantly suppress the PLR [38], we cannot exclude the possibility that other medications such as propofol may have affected the PLR [39]. Third, we did not analyze confounders such as underlying pathology of the retina or optic nerve as well as the influence of ambient lights on the PLR [40].

Conclusions

In conclusion, reduced reactivity and increased size of pupils were related to BHS in patients with HOU. Moreover, reduced pupillary reactivity was associated with in-hospital mortality and poor neurological outcomes at 3-months. These findings suggest that QP measurement may be useful for early detection of potentially life-threatening neurological conditions in non-neurological in-patients who develop unconsciousness.

Abbreviations

BHS brain herniation syndrome

CH percentage of change

CI confidence interval

CT computed tomography

CV constriction velocity

DV dilation velocity

EEG electroencephalography

GCS Glasgow Coma Scale

HOU hospital-onset unconsciousness

Lat latency of constriction

Max maximal pupillary diameter

Min minimal pupillary diameter

MRI magnetic resonance imaging

mRS modified Rankin Scale

NAT Neurological Alert Team

NPi Neurological Pupil index

OR odds ratio

PLR pupillary light reflexes

QP quantitative pupillometery

Declarations

Manuscript complies with all instructions to authors. Authorship requirements have been met and the final manuscript was approved by all authors. This manuscript has not been published elsewhere and is not under consideration by another journal.

Availability of data and materials

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Ethics approval

This study was approved by the institutional review board of Asan Medical Center and the need for written informed consent was waived considering the retrospective nature of the study.

Conflicts of interest

The authors declare that they have no conflict of interest

Funding

This study was supported by grants of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant numbers: HI18C1487 and HI18C2383).

Authors' contributions

H.L., S.H.C. and S.-B.J. contributed to the conception and design of the study; H.L., S.H.C., B.P., Y.-H.H., H.B.L., and S.-B.J. recruited the participants and collected the data; H.L. and S.-B.J. analyzed and interpreted the data, performed literature search, and wrote the manuscript; H.L. prepared the figures; all authors appraised and edited the manuscript, and approved its final version for submission.

Acknowledgements

None

References

  1. Kanich W, Brady WJ, Huff JS, et al. Altered mental status: evaluation and etiology in the ED. Am J Emerg Med 2002;20(7):613-7.
  2. Sprung CL, Peduzzi PN, Shatney CH, et al. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Critical care medicine 1990;18(8):801-6.
  3. Clusmann H, Schaller C, Schramm J. Fixed and dilated pupils after trauma, stroke, and previous intracranial surgery: management and outcome. J Neurol Neurosurg Psychiatry 2001;71(2):175-81.
  4. Olson DM, Stutzman S, Saju C, et al. Interrater reliability of pupillary assessments. Neurocrit Care 2016;24(2):251-7.
  5. Couret D, Boumaza D, Grisotto C, et al. Reliability of standard pupillometry practice in neurocritical care: an observational, double-blinded study. Crit Care 2016;20:99.
  6. Zhao W, Stutzman S, DaiWai O, et al. Inter-device reliability of the NPi-100 pupillometer. J Clin Neurosci 2016;33:79-82.
  7. Soeken TA, Alonso A, Grant A, et al. Quantitative pupillometry for detection of intracranial pressure changes during head-down tilt. Aerosp Med Hum Perform 2018;89(8):717-23.
  8. Chen JW, Gombart ZJ, Rogers S, et al. Pupillary reactivity as an early indicator of increased intracranial pressure: The introduction of the Neurological Pupil index. Surg Neurol Int 2011;2:82.
  9. Chen JW, Vakil-Gilani K, Williamson KL, Cecil S. Infrared pupillometry, the Neurological Pupil index and unilateral pupillary dilation after traumatic brain injury: implications for treatment paradigms. Springerplus 2014;3:548.
  10. Taylor WR, Chen JW, Meltzer H, et al. Quantitative pupillometry, a new technology: normative data and preliminary observations in patients with acute head injury. Technical note. J Neurosurg 2003;98(1):205-13.
  11. Obling L, Hassager C, Illum C, et al. Prognostic value of automated pupillometry: an unselected cohort from a cardiac intensive care unit. Eur Heart J Acute Cardiovasc Care 2019:2048872619842004.
  12. Tamura T, Namiki J, Sugawara Y, et al. Quantitative assessment of pupillary light reflex for early prediction of outcomes after out-of-hospital cardiac arrest: A multicentre prospective observational study. Resuscitation 2018;131:108-13.
  13. Oddo M, Sandroni C, Citerio G, et al. Quantitative versus standard pupillary light reflex for early prognostication in comatose cardiac arrest patients: an international prospective multicenter double-blinded study. Intensive Care Med 2018;44(12):2102-11.
  14. Elmer J. Quantitative pupillometry after cardiac arrest. Resuscitation 2018;131:A1-a2.
  15. Solari D, Rossetti AO, Carteron L, et al. Early prediction of coma recovery after cardiac arrest with blinded pupillometry. Ann Neurol 2017;81(6):804-10.
  16. Suys T, Bouzat P, Marques-Vidal P, et al. Automated quantitative pupillometry for the prognostication of coma after cardiac arrest. Neurocrit Care 2014;21(2):300-8.
  17. Heimburger D, Durand M, Gaide-Chevronnay L, et al. Quantitative pupillometry and transcranial Doppler measurements in patients treated with hypothermia after cardiac arrest. Resuscitation 2016;103:88-93.
  18. Hasan S, Peluso L, Ferlini L, et al. Correlation between electroencephalography and automated pupillometry in critically ill patients: A pilot study. J Neurosurg Anesthesiol 2019.
  19. Solari D, Miroz JP, Oddo M, et al. Opening a window to the injured brain: Non-invasive neuromonitoring with quantitative pupillometry, in Annual Update in Intensive Care and Emergency Medicine 2018, J.-L. Vincent, Editor 2018, Springer International Publishing: Cham. p. 503-18.
  20. Jeon SB, Lee HB, Koo YS, et al. Neurological emergencies in patients hospitalized with non-neurological illness. Journal of Patient Safety 2020.
  21. Gill M, Martens K, Lynch EL, Salih A, Green SM. Interrater reliability of 3 simplified neurologic scales applied to adults presenting to the emergency department with altered levels of consciousness. Ann Emerg Med 2007;49(4):403-7, 7.e1.
  22. van Swieten JC, Koudstaal PJ, Visser MC, Schouten H, J van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19(5):604-7.
  23. Hirzallah MI, Choi HA. The monitoring of brain edema and intracranial hypertension. J Neurocrit Care 2016;9(2):92-104.
  24. Boev AN, Fountas KN, Karampelas I, et al. Quantitative pupillometry: normative data in healthy pediatric volunteers. J Neurosurg 2005;103(6 Suppl):496-500.
  25. Theodossiadis PG, AchtsidisV, Theodoropoulou S, et al. The effect of alpha antagonists on pupil dynamics: implications for the diagnosis of intraoperative floppy iris syndrome. Am J Ophthalmol 2012;153(4):620-6.
  26. Wilson MH, Edsell M, Imray C, Wright A. Changes in pupil dynamics at high altitude--an observational study using a handheld pupillometer. High Alt Med Biol 2008;9(4):319-25.
  27. Ong C, Hutch M, Barra M, et al. Effects of osmotic therapy on pupil reactivity: Quantification using pupillometry in critically Ill neurologic patients. Neurocrit Care 2019;30(2):307-15.
  28. Kim HM, Yang HK, Hwang JM. Quantitative analysis of pupillometry in isolated third nerve palsy. PLoS One 2018;13(11):e0208259.
  29. Natzeder S, Mack DJ, Maissen G, et al. Portable Infrared Pupillometer in Patients With Subarachnoid Hemorrhage: Prognostic Value and Circadian Rhythm of the Neurological Pupil Index (NPi). J Neurosurg Anesthesiol 2019;31(4):428-33.
  30. Rouche O, Wolak-Thierry A, Destoop Q, et al. Evaluation of the depth of sedation in an intensive care unit based on the photo motor reflex variations measured by video pupillometry. Ann Intensive Care 2013;3(1):5.
  31. Brazis P, Masdeu JC, Biller J. Localization in Clinical Neurology. 7 ed2016, Philadelphia: Lippincott Williams & Wilkins.
  32. Ritter AM, Muizelaar JP, Barnes T, et al. Brain stem blood flow, pupillary response, and outcome in patients with severe head injuries. Neurosurgery 1999;44(5):941-8.
  33. Reimer J, McGinley MJ, Liu Y, et al. Pupil fluctuations track rapid changes in adrenergic and cholinergic activity in cortex. Nat Commun 2016;7:13289.
  34. Larsen RS, Waters J. Neuromodulatory correlates of pupil dilation. Front Neural Circuits 2018;12(21):21.
  35. Peinkhofer C, Knudsen GM, Moretti R, Kondziella D. Cortical modulation of pupillary function: systematic review. PeerJ 2019;7:e6882.
  36. van Gool WA, van de Beek D, Eikelenboom P. Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet 2010;375(9716):773-5.
  37. Yang E, Kreuzer M, Hesse S, et al. Infrared pupillometry helps to detect and predict delirium in the post-anesthesia care unit. J Clin Monit Comput 2018;32(2):359-68.
  38. Shirozu K, Setoguchi H, Tokuda K, et al. The effects of anesthetic agents on pupillary function during general anesthesia using the automated infrared quantitative pupillometer. J Clin Monit Comput 2017;31(2):291-6.
  39. Haddock JH, Mercante DE, Paccione R, et al. Use of digital pupillometry to measure sedative response to propofol. Ochsner J 2017;17(3):250-3.
  40. Ong C, Hutch M, Smirnakis S. The effect of ambient light conditions on quantitative pupillometry. Neurocrit Care 2019;30(2):316-21.